Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie


Research facility

Location:
Stuttgart, Germany


Publications in cooperation with FAU scientists


Aghamaliyev, U., Gaitantzi, H., Thomas, M., Simon-Keller, K., Gaiser, T., Marx, A.,... Breitkopf-Heinlein, K. (2019). Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells. European Surgical Research, 1-12. https://dx.doi.org/10.1159/000494734
Schaeffeler, E., Büttner, F., Reustle, A., Klumpp, V., Winter, S., Rausch, S.,... Schwab, M. (2018). Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. European Urology Focus. https://dx.doi.org/10.1016/j.euf.2018.01.016
Fisel, P., Buettner, F., Reustle, A., Klumpp, V., Winter, S., Rausch, S.,... Schaeffeler, E. (2018). Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A.,... Simard, J. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, 7(49), 80140-80163. https://dx.doi.org/10.18632/oncotarget.12818

Last updated on 2018-07-08 at 15:46